CD71 may delineate a population of protective resident AMs, whereas monocyte-derived AMs are defined by a lack of CD71− expression and drive pathology during IPF, analogous to AMs found in murine models of fibrosing lung disease (13). This evidence concerns the gene TFRC and lung disorder.